Debdulal Chakraborty

419 total citations
43 papers, 251 citations indexed

About

Debdulal Chakraborty is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Debdulal Chakraborty has authored 43 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Ophthalmology, 22 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Neurology. Recurrent topics in Debdulal Chakraborty's work include Retinal Diseases and Treatments (21 papers), Retinal and Optic Conditions (14 papers) and Retinal Imaging and Analysis (11 papers). Debdulal Chakraborty is often cited by papers focused on Retinal Diseases and Treatments (21 papers), Retinal and Optic Conditions (14 papers) and Retinal Imaging and Analysis (11 papers). Debdulal Chakraborty collaborates with scholars based in India, United States and United Kingdom. Debdulal Chakraborty's co-authors include Tushar Sinha, Jay Sheth, K. C. Majumdar, Harsha Bhattacharjee, Dipankar Das, Kasturi Bhattacharjee, Angshuman Mukherjee, Sabyasachi Sengupta, Swapan K. Ghosh and Nikulaa Parachuri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cataract & Refractive Surgery and Planta Medica.

In The Last Decade

Debdulal Chakraborty

33 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debdulal Chakraborty India 9 184 117 22 20 15 43 251
Fangying Lu China 7 27 0.1× 13 0.1× 9 0.4× 10 0.5× 28 1.9× 17 145
Nikolaos Papazoglou Greece 5 23 0.1× 14 0.1× 21 1.0× 9 0.5× 23 1.5× 7 94
Ewa Bogacka Poland 6 28 0.2× 28 0.2× 80 3.6× 9 0.5× 9 0.6× 16 306
George E. McLaughlin United States 7 29 0.2× 4 0.0× 49 2.2× 22 1.1× 12 0.8× 10 127
Chuan Nie China 8 14 0.1× 54 0.5× 1 0.0× 18 0.9× 49 3.3× 30 176
Marie Claude Guertin Canada 6 9 0.0× 42 0.4× 1 0.0× 43 2.1× 11 0.7× 11 132
Peipei Kang China 6 12 0.1× 5 0.0× 4 0.2× 10 0.5× 16 1.1× 10 106
W. Ennis James United States 6 9 0.0× 4 0.0× 16 0.7× 28 1.4× 24 1.6× 21 199
Omar Sheikh United States 7 14 0.1× 7 0.1× 1 0.0× 18 0.9× 26 1.7× 21 86

Countries citing papers authored by Debdulal Chakraborty

Since Specialization
Citations

This map shows the geographic impact of Debdulal Chakraborty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debdulal Chakraborty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debdulal Chakraborty more than expected).

Fields of papers citing papers by Debdulal Chakraborty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debdulal Chakraborty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debdulal Chakraborty. The network helps show where Debdulal Chakraborty may publish in the future.

Co-authorship network of co-authors of Debdulal Chakraborty

This figure shows the co-authorship network connecting the top 25 collaborators of Debdulal Chakraborty. A scholar is included among the top collaborators of Debdulal Chakraborty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debdulal Chakraborty. Debdulal Chakraborty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chakraborty, Debdulal, et al.. (2025). Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational Study. Clinical ophthalmology. Volume 19. 269–277. 2 indexed citations
2.
Sharma, Ashish, et al.. (2025). Ranibizumab biosimilar (Oceva) – real-world experience from India (RORE study). Expert Opinion on Biological Therapy. 25(12). 1353–1358.
3.
Sharma, Ashish, Frank G. Holz, Nilesh Kumar, et al.. (2025). Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study. Journal of VitreoRetinal Diseases. 9(3). 330–335. 1 indexed citations
4.
Chakraborty, Debdulal, et al.. (2025). CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS Study. Clinical ophthalmology. Volume 19. 1093–1102.
5.
Chakraborty, Debdulal, Ashish Sharma, Soumen Mondal, et al.. (2024). Brolucizumab versus aflibercept for recalcitrant diabetic macular edema in Indian real-world scenario – The BRADIR study. American Journal of Ophthalmology Case Reports. 36. 102152–102152. 5 indexed citations
6.
Chakraborty, Debdulal, et al.. (2023). Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence. Clinical ophthalmology. Volume 17. 1067–1076. 10 indexed citations
8.
Chakraborty, Debdulal, et al.. (2022). Two intraocular lenses in the anterior chamber. Indian Journal of Ophthalmology - Case Reports. 2(2). 622–622.
9.
Chakraborty, Debdulal, et al.. (2022). Comparison of Innovator vs. Biosimilar Ranibizumab in Treating Diabetic Macular Edema: A Multicenter Retrospective Study. Ophthalmology and Therapy. 11(2). 629–638. 6 indexed citations
10.
Chakraborty, Debdulal, et al.. (2021). Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series. American Journal of Ophthalmology Case Reports. 24. 101197–101197. 27 indexed citations
11.
Chakraborty, Debdulal, et al.. (2021). Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study. Clinical ophthalmology. Volume 15. 3787–3795. 37 indexed citations
12.
Chakraborty, Debdulal, et al.. (2021). Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases. Ophthalmology and Therapy. 10(2). 337–348. 19 indexed citations
13.
Chakraborty, Debdulal, et al.. (2021). Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment – A quasi-randomized retrospective study. Indian Journal of Ophthalmology. 69(11). 3283–3287. 2 indexed citations
14.
Chakraborty, Debdulal, et al.. (2021). A curious case of macular edema in persistent fetal vasculature. Indian Journal of Ophthalmology - Case Reports. 1(3). 416–417.
15.
Chakraborty, Debdulal, et al.. (2020). B-HEX pupil expander in vitreoretinal surgery – A case series. Indian Journal of Ophthalmology. 68(6). 1188–1188. 4 indexed citations
16.
Chakraborty, Debdulal, et al.. (2016). Cut Throat Injury: Our Experience in Rural Set-Up. Indian Journal of Otolaryngology and Head & Neck Surgery. 69(1). 35–41. 6 indexed citations
17.
Ghosh, Swapan K., et al.. (2008). Neurofibroma of the external ear - a case report. Indian Journal of Otolaryngology and Head & Neck Surgery. 60(3). 289–290. 7 indexed citations
18.
Saha, Somnath, et al.. (2008). Occult foreign bodies in the aero digestive tracts in infancy. Indian Journal of Otolaryngology and Head & Neck Surgery. 60(1). 37–40. 1 indexed citations
19.
Saha, Somnath, et al.. (2007). Sarcomas of head and neck — A 10 yrs experience. Indian Journal of Otolaryngology and Head & Neck Surgery. 59(4). 322–326. 10 indexed citations
20.
Bhattacharjee, Harsha, et al.. (2004). Management of a posteriorly dislocated endocapsular tension ring and a foldable acrylic intraocular lens. Journal of Cataract & Refractive Surgery. 30(1). 243–246. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026